Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1986-07-31
1992-01-07
Kepplinger, Esther L.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 8, 514 21, 424 858, 424 93, 435 695, 4351722, 4351723, 530350, 530351, 530387, 530828, A61K 4505, A61K 3766
Patent
active
050789961
ABSTRACT:
Macrophages and precursor monocytes are activated to exhibit tumoricidal activity by stimulation solely with granulocyte-macrophage colony stimulating factor. A patient suffering from tumors can be treated by direct administration of therapeutically effective quantities of activated granulocyte-macrophage colony stimulating factor. Homogeneous granulocyte-macrophage colony stimulating factor for use in activating macrophages and monocyte precursors is prepared by recombinant DNA techniques. The gene coding for granylocyte-macrophage colony stimulating factor is isolated and then recombinant protein product expressed in an appropriate expression system. The granulocyte-macrophage colony stimulating factor recovered from the expression system is purified to homogeneity by reverse phase high-performance liquid chromatography.
REFERENCES:
patent: 4342828 (1982-08-01), Takaku et al.
patent: 4438032 (1984-03-01), Golde et al.
patent: 4675291 (1987-06-01), Yamamura et al.
Binz et al, J. Exp. Med., 147, 63-76, (1978).
Berendt et al, J. Exp. Med., 151, 69, (1980).
Nepom et al, Experentia, 39(3), 235-242, (1983).
Flood et al., J. Exp. Med.; 154, 275-290, (1981).
Flood et al, PNAS, 77(3), 2209-2213, (Apr. 1980).
Stevenson et al, J. Immunol., 130(2), 970, (1983).,
Den Otter, Lymphokines, 3, p. 389, (1981).
Moore et al, Lymplokines, 3, 119, (1981).
Grabstein et al, Science, 232, 506-508, (Apr. 1986).
Nathan et al, J. Exp. Med., 160, 600-605, (1984).
Handman, J. Imm., 122(3), 1134, (1979).
Nelson, in "Phagocytes & Cell. Immunity", (Gadebusch, Ed), CRC Press (1979).
Lang et al, Cell, 51, 675-686, (Nov. 1987).
Adams et al, Ann. Rev. Imm., 2: 283-318, (1984).
Arnaut et al, J. Clin. Invest., 78, 597-60, 1986.
Burgess et al, Blood, 56 (6), 947, (1980).
Lopez et al, J. Immunol., 131(6), (Dec. 1983), pp. 2983-2988.
Clark et al, Science, 236, 1229-1237, (Jun. 1987).
Weishart et al, Nature, 314, 361-364, (Mar. 1985).
Nicola et al, Blood, 54(3), 614, (1979).
Handman et al, J. Immunol., 122(3), 1134-1137, (1979).
Wing et al, J. Clin. Investigation, 69, 270-276, 1982.
Ralph et al, Chem. Abs., 98:158918p, 1983.
Meltzer, Lymphokines, vol. 3, pp. 319-343, 1981.
Moore et al, Lymphokines, vol. 3, 119-148, 1981.
Gough et al, Nature, 309, pp. 763-767, Jun. 1984.
Moore et al, J. Immunol., 125(3), 1302-1305, 1980.
Cameron et al., "Cytotoxicity of Human Macrophages for Tumor Cells", J. Clin. Invest. 63:977 (1979).
Mantovani et al., "Augmentation of Tumoricidal Activity of Human Monocytes and Macrophages by Lumphokines", Int. J. Cancer 25:691 (1980).
Kleinerman et al., "Tumoricidal Activity of Human Monocytes Activated In Vitro by Free and Liposome-encapsulated Human Lymphokines", J. Clin. Invest. 72:304 (1983).
Roberts and Vasil, J. Interferon Res. 2:519 (1982).
Svedersky et al., "Biological and Antigenic Similarities of Murine Interferon and Macrophage-Activating Factor", J. Exp. Med. 159:812 (1984).
Onozaki et al., "Role of Interleukin 1 in Promoting Human Monocyte-Mediated Tumor Cytotoxicity", J. Immunol., 135:314 (1985).
Sone et al., "In Vitro Generation of Tumoricidal Properties in Human Alveolar Macrophages Following Interaction with Endotoxin", Cancer Res. 42:2227 (1982).
Pick et al., "Intracellular Mediation of Lymphokine Action: Minicry of Migration Inhibitory Factor (MIF) Action by Phorbol Myristate (PMA) and the Ionophore A23187", Ann. N.Y. Acad. Sci. 332:378 (1979).
Hand et al., "Requirement for Magnesium Influx in Activation of Alveolar Macrophages Mediated by Ionophore A23187", Nature (London) 265:543 (1979).
Schultz et al., J. Interfon Res. 2:459 (1982).
Conlon, III Paul J.
Grabstein Kenneth H.
Hallquist Scott G.
Immunex Corporation
Kepplinger Esther L.
Kushan Jeff
Nagae Jerald A.
LandOfFree
Activation of macrophage tumoricidal activity by granulocyte-mac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Activation of macrophage tumoricidal activity by granulocyte-mac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Activation of macrophage tumoricidal activity by granulocyte-mac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-820573